NEWARK, Del. and NANJING, China, Feb. 19, 2025 /PRNewswire/ — Biosion, Inc. (“Biosion”), a global clinical-stage biotechnology company, is pleased to announce the appointment of Kedan Lin, Ph.D., as Chief Development Officer and President of Biosion US. With over two decades of expertise…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.